(Etokimab)Biosimilar Reference Antibody-GS40246

货号：GS40246

Etokimab (development code ANB020) is an investigational, humanized monoclonal IgG1 antibody developed for the treatment of type 2 inflammatory diseases, such as moderate-to-severe atopic dermatitis (eczema) and severe asthma. It functions as a precision cytokine inhibitor, specifically designed to bind and neutralize a key upstream mediator in the type 2 immune cascade. By targeting this cytokine, etokimab aims to intercept the inflammatory pathway at an early, pivotal point, thereby reducing the production of downstream effectors (like IL-4, IL-5, and IL-13) and the resulting inflammation, tissue damage, and symptoms associated with these allergic and eosinophilic conditions.